National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 6) (Cth)
PB 74 of 2022
National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 6)
I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.
Dated 28 July 2022
NIKOLAI TSYGANOV
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
1 Name........................................................................................................................................ 1
2 Commencement........................................................................................................................ 1
3 Authority.................................................................................................................................. 1
4 Schedules................................................................................................................................. 1
Schedule 1—Amendments 2
National Health (Price and Special Patient Contribution) Determination 2021 (PB 35 of 2021) 2
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2022 (No. 6).
This instrument may also be cited as PB 74 of 2022.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 August 2022 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2021 (PB 35 of 2021)
Schedule 1, entry for Ezetimibe
Omit
| Ezetimibe | Tablet 10 mg | Oral | Ezetrol | 30 | 8.28 | 11.01 |
Insert
| Ezetimibe | Tablet 10 mg | Oral | Ezetrol | 30 | 8.28 | 11.44 |
Schedule 1, entry for Ezetimibe and rosuvastatin
Omit
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Rosuzet Composite Pack | 1 | 9.39 | 12.69 |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Rosuzet Composite Pack | 1 | 10.83 | 14.17 | |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Rosuzet Composite Pack | 1 | 10.59 | 13.94 | |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Rosuzet Composite Pack | 1 | 11.57 | 14.96 |
Substitute
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Rosuzet Composite Pack | 1 | 9.39 | 13.11 |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Rosuzet Composite Pack | 1 | 10.83 | 14.55 | |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Rosuzet Composite Pack | 1 | 10.59 | 14.31 | |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Rosuzet Composite Pack | 1 | 11.57 | 15.29 |
Schedule 1, after entry for Ezetimibe and rosuvastatin
Insert
| Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Atozet | 30 | 9.70 | 12.49 |
| Tablet 10 mg-20 mg | Oral | Atozet | 30 | 10.38 | 13.17 | |
| Tablet 10 mg-40 mg | Oral | Atozet | 30 | 11.23 | 14.02 | |
| Tablet 10 mg-80 mg | Oral | Atozet | 30 | 12.50 | 15.29 |
Schedule 1, entry for Metformin
Omit
| Metformin | Tablet containing metformin hydrochloride 500 mg | Oral | Diabex | 100 | 2.50 | 7.11 |
| Tablet (extended release) containing metformin hydrochloride 500 mg | Oral | Diabex XR 500 | 120 | 4.01 | 8.61 | |
| Tablet containing metformin hydrochloride 850 mg | Oral | Diabex 850 | 60 | 2.50 | 7.11 | |
| Tablet containing metformin hydrochloride 1 g | Oral | Diabex 1000 | 90 | 4.36 | 8.97 | |
| Tablet (extended release) containing metformin hydrochloride 1 g | Oral | Diabex XR 1000 | 60 | 4.01 | 8.61 |
Substitute
| Metformin | Tablet containing metformin hydrochloride 500 mg | Oral | Diabex | 100 | 2.50 | 7.59 |
| Tablet (extended release) containing metformin hydrochloride 500 mg | Oral | Diabex XR 500 | 120 | 4.01 | 8.99 | |
| Tablet containing metformin hydrochloride 850 mg | Oral | Diabex 850 | 60 | 2.50 | 7.59 | |
| Tablet containing metformin hydrochloride 1 g | Oral | Diabex 1000 | 90 | 4.36 | 9.32 | |
| Tablet (extended release) containing metformin hydrochloride 1 g | Oral | Diabex XR 1000 | 60 | 4.01 | 8.99 |
Schedule 1, entry for Telmisartan
Omit
| Telmisartan | Tablet 40 mg | Oral | Micardis | 28 | 1.65 | 5.83 |
| Tablet 80 mg | Oral | Micardis | 28 | 4.78 | 8.97 |
Insert
| Telmisartan | Tablet 40 mg | Oral | Micardis | 28 | 1.65 | 6.86 |
| Tablet 80 mg | Oral | Micardis | 28 | 4.78 | 9.76 |
Schedule 1, entry for Telmisartan with amlodipine
Omit
| Telmisartan with amlodipine | Tablet 40 mg‑5 mg (as besilate) | Oral | Twynsta | 28 | 2.42 | 6.60 |
| Tablet 40 mg‑10 mg (as besilate) | Oral | Twynsta | 28 | 3.02 | 7.21 | |
| Tablet 80 mg‑5 mg (as besilate) | Oral | Twynsta | 28 | 5.55 | 9.74 | |
| Tablet 80 mg‑10 mg (as besilate) | Oral | Twynsta | 28 | 6.15 | 10.33 |
Substitute
| Telmisartan with amlodipine | Tablet 40 mg‑5 mg (as besilate) | Oral | Twynsta | 28 | 2.42 | 7.56 |
| Tablet 40 mg‑10 mg (as besilate) | Oral | Twynsta | 28 | 3.02 | 8.12 | |
| Tablet 80 mg‑5 mg (as besilate) | Oral | Twynsta | 28 | 5.55 | 10.48 | |
| Tablet 80 mg‑10 mg (as besilate) | Oral | Twynsta | 28 | 6.15 | 11.08 |
Schedule 1, entry for Telmisartan with hydrochlorothiazide
Omit
| Telmisartan with hydrochlorothiazide | Tablet 40 mg‑12.5 mg | Oral | Micardis Plus 40/12.5 mg | 28 | 2.12 | 6.31 |
| Tablet 80 mg‑12.5 mg | Oral | Micardis Plus 80/12.5 mg | 28 | 5.29 | 9.48 | |
| Tablet 80 mg‑25 mg | Oral | Micardis Plus 80/25 mg | 28 | 5.76 | 9.94 |
Substitute
| Telmisartan with hydrochlorothiazide | Tablet 40 mg‑12.5 mg | Oral | Micardis Plus 40/12.5 mg | 28 | 2.12 | 7.28 |
| Tablet 80 mg‑12.5 mg | Oral | Micardis Plus 80/12.5 mg | 28 | 5.29 | 10.23 | |
| Tablet 80 mg‑25 mg | Oral | Micardis Plus 80/25 mg | 28 | 5.76 | 10.69 |
0
0
0